Based on these metrics and many more, GEHC holds a Value grade of B, while PODD has a Value grade of D. GEHC has seen stronger estimate revision activity and sports more attractive valuation ...
Insulet Corporation PODD announced favorable RADIANT trial clinical data for its Omnipod 5 at the 18th International Conference on Advanced Technologies and Treatments for Diabetes (“ATTD”).